Vanda Pharmaceuticals (VNDA) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to -$293.8 million.
- Vanda Pharmaceuticals' Enterprise Value rose 2192.87% to -$293.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.8 million, marking a year-over-year increase of 2192.87%. This contributed to the annual value of -$374.6 million for FY2024, which is 350.82% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Enterprise Value stood at -$293.8 million for Q3 2025, which was up 2192.87% from -$325.6 million recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Enterprise Value ranged from a high of -$293.8 million in Q3 2025 and a low of -$501.5 million during Q1 2023
- Its 5-year average for Enterprise Value is -$409.1 million, with a median of -$396.5 million in 2021.
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 2107.93% in 2021, then skyrocketed by 2318.98% in 2024.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Enterprise Value stood at -$432.8 million in 2021, then fell by 7.87% to -$466.9 million in 2022, then grew by 16.83% to -$388.3 million in 2023, then grew by 3.51% to -$374.6 million in 2024, then grew by 21.59% to -$293.8 million in 2025.
- Its Enterprise Value stands at -$293.8 million for Q3 2025, versus -$325.6 million for Q2 2025 and -$340.9 million for Q1 2025.